Gryan,
I agree with what the other comments made by Jeff and Michelle here. It is certainly nice for patients to have options regarding whether they want to take TMP-SMX 3x weekly vs once daily and DS vs SS. If you go to the DHHS guidelines you'll see that TMP-SMX DS or SS qDay both have level A1 ratings, whereas 3x weekly has a level B1 rating. Something to consider as well but do what works for your patients. Much of our data around prophylaxis is in the era before HAART. I think many would agree now that the vast majority of prophylactic benefit is actually going to be from the ART itself, as compared to the antimicrobial ppx such as TMP-SMX.
I also want to say that the decisions around prophylaxis should be informed in part by your patient population as well. What I mean by that is this: some positive care clinics seldom see new patients present so late to care with stage 3 clinical criteria (AIDS). However, at our clinic in LA County and our positive care team on Skid Row we very frequently see patients present very late to care. We may also see patients who have been out of care for many years and now have AIDS. So the incidence of PCP or other OI's may be higher among our cohort of patients who, in aggregate, are more likely to have AIDS. So we are pretty cautious with ppx because of our patient population.
Hope everyone is staying safe out there!
------------------------------
Michael Stefanowicz
Los Angeles CA
------------------------------
Original Message:
Sent: 03-22-2020 17:38
From: Gryan Eroll Garcia
Subject: Prophylaxis for Pneumocystis pneumonia (PCP)
Hi All. Do you routinely use prophylaxis for Pneumocystis pneumonia (PCP) for patient with CD4 less than 200 copies? If so, which regimen do you use? TMP/SMX DS once a day? SS once a day? or DS three times per week? or any others?
Thanks,
Gryan
------------------------------
Gryan Eroll Garcia
Scottsdale AZ
------------------------------